Cited by 228Nuclear Structure and FunctionDNA Repair MechanismsTelomeres, Telomerase, and Senescence

DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A

Open access
Liu, Yiyong, Rusinol, Antonio, Sinensky, Michael, Wang, Youjie, Zou, Yue·2006·Journal of Cell Science

Abstract

The genetic diseases Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (RD) arise from accumulation of farnesylated prelamin A because of defects in the lamin A maturation pathway. Both of these diseases exhibit symptoms that can be viewed as accelerated aging. The mechanism by which accumulation of farnesylated prelamin A leads to these accelerated aging phenotypes is not understood. Here we present evidence that in HGPS and RD fibroblasts, DNA damage checkpoints are persistently activated because of the compromise in genomic integrity. Inactivation of checkpoint kinases Ataxia-telangiectasia-mutated (ATM) and ATR (ATM- and Rad3-related) in these patient cells can partially overcome their early replication arrest. Treatment of patient cells with a protein farnesyltransferase inhibitor (FTI) did not result in reduction of DNA double-strand breaks and damage checkpoint signaling, although the treatment significantly reversed the aberrant shape of their nuclei. This suggests that DNA damage accumulation and aberrant nuclear morphology are independent phenotypes arising from prelamin A accumulation in these progeroid syndromes. Since DNA damage accumulation is an important contributor to the symptoms of HGPS, our results call into question the possibility of treatment of HGPS with FTIs alone.

AI snapshot

Written from the paper’s full text.

TL;DR

In HGPS and RD fibroblasts, accumulation of farnesylated prelamin A/progerin is associated with persistent DNA damage checkpoint activation, and inactivating ATM/ATR partially restores DNA synthesis. FTI treatment corrects aberrant nuclear shape but does not reduce DNA double-strand breaks or checkpoint signaling, suggesting these are independent phenotypes.

Key findings

  • HGPS and RD cells showed persistent DNA damage checkpoint activation: ATM nuclear foci, ATR nuclear translocation/foci, and phosphorylation of H2AX, Chk1 (Ser-345), Chk2 (Thr-68), and p53 (Ser-15).
  • DNA synthesis in HGPS and RD cells at passage 11 was more than 2-fold slower than in BJ cells; replicative capacity was lost at passage 15 for RD cells and passage 21 for HGPS cells.
  • Knockdown of ATM and ATR by siRNA, or treatment with 5 mM caffeine, significantly increased DNA synthesis in HGPS cells but had no obvious effect on control BJ cells.
  • FTI L-744832 reduced misshapen nuclei from 47% to 11% in RD cells (P<0.005) and from 33% to 6% in HGPS cells (P<0.001), but did not substantially reduce γ-H2AX, comet-assay DNA damage, or Chk1/Chk2 phosphorylation. Expression of farnesylation-incompetent LAΔ50-SIIM and LAΔ50 induced similar γ-H2AX accumulation in HeLa cells.

Methods

  • Cell-based study using HGPS fibroblasts (Coriell no. AG11513A), human RD fibroblasts, BJ fibroblasts, and HeLa cells; treatments included 5 μM FTI L-744832 daily for 72 hours and 5 mM caffeine.
  • DNA synthesis measured by [methyl-3H]thymidine incorporation; checkpoint activation assessed by immunofluorescence microscopy and Western blotting for ATM, ATR, γ-H2AX, Chk1, Chk2, and p53 phosphorylation.
  • DNA damage measured by neutral comet assay; siRNA knockdown of ATR and ATM, and transfection of pEGFP-LAΔ50, pEGFP-LAΔ50-SIIM, or control plasmids were used to test effects of progerin and farnesylation status.

Limitations

  • The paper states that only partial restoration of S-phase progression was observed after ATM/ATR inactivation, likely because DNA damage responses were incompletely repressed and residual kinase activity may suffice to enforce a checkpoint.
  • The paper notes a discrepancy with another study on ATR localization, attributing it to ectopic FLAG-ATR expression versus endogenous ATR staining in normal cells.
  • Evident from the text: findings are limited to cultured patient fibroblasts and HeLa overexpression models, with no in vivo data; FTI may not completely abolish progerin farnesylation, although the authors also used a prenylation-incompetent LAΔ50-SIIM construct to address this.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1242/jcs.03263

Cites

Statistics

Nothing to recompute.

Claims the paper makes

0 of 18 cited sources checked · 0 supported · 0 flagged

  • Findingown data
    § Discussion

    Activation of ATR and ATM in patient cells as evidenced by immunofluorescence was confirmed by phosphorylation of downstream substrates Chk1, Chk2, and p53.

    “In the present study, activation of ATR and ATM in the patient cells as evidenced by immunofluorescence determination was confirmed by the phosphorylation of their downstream substrates Chk1, Chk2, and p53 as analyzed by Western blotting.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Results

    Chk1 and Chk2 phosphorylation was equally efficient in HGPS cells with or without FTI treatment.

    “Importantly, the phosphorylation was equally efficient in the cells with or without FTI treatment.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Results

    No substantial reduction of DNA double-strand breaks was detected in HGPS and RD cells after FTI treatment, as evidenced by γ-H2AX.

    “By contrast, however, no substantial reduction of DSBs was detected in HGPS and RD cells after FTI treatment, as evidenced by the amount of γ-H2AX analyzed by Western blotting (Fig. 5B).”
    Quote in the paperSubstantial claim
  • Findingown data
    § Results

    ATR was activated in HGPS and RD cells, as indicated by its nuclear distribution.

    “The nuclear distribution of ATR in RD and HGPS cells suggests its activation in these cells, which is confirmed by the phosphorylation of its primary substrate Chk1 (see below).”
    Quote in the paperSubstantial claim
  • Findingown data
    § Summary

    FTI treatment did not reduce DNA damage checkpoint signaling in HGPS and RD patient cells.

    “Treatment of patient cells with a protein farnesyltransferase inhibitor (FTI) did not result in reduction of DNA double strand breaks and damage checkpoint signaling, although the treatment significantly reversed the aberrant shape of their nuclei.”
    • Also stated in: § Results · plain
      “Importantly, the phosphorylation was equally efficient in the cells with or without FTI treatment.”
    Quote in the paperSubstantial claim
  • May combine two claims. 10
  • Classified as probably not a substantial claim. 3
  • May combine two claims.

    Findingown data
    § Results

    Replicative capacity was lost at passage 15 for RD cells and at passage 21 for HGPS cells.

    “Moreover, replicative capacity was lost at passage 15 for RD cells and at passage 21 for HGPS cells (Fig. 1) in contrast to the more typical replicative behavior of BJ cells which exhibit many more passages before undergoing replicative senescence (Steinert et al., 2000).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Results

    Knockdown of ATM and ATR by siRNA significantly increased DNA synthesis in HGPS cells, while having no obvious effect on control BJ cells.

    “As shown in Fig. 4B, the knockdown significantly increased DNA synthesis in HGPS cells, while having no obvious effect on that of the control BJ cells.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given
    § Discussion

    Inactive ATM is homogenously distributed in the nucleus, while nuclear focus formation of ATM indicates its activation.

    “Inactive ATM is homogenously distributed in the nucleus, while nuclear focus formation of ATM indicates its activation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data
    § Results

    Phosphorylation of Chk1 (Ser-345), Chk2 (Thr-68), and p53 (Ser-15) were all readily detected in HGPS and RD cells, confirming activation and signaling of checkpoint pathways.

    “As shown in Fig. 3, besides phosphorylation of H2AX, phosphorylation of Chk1 (Ser-345), Chk2 (Thr-68), and p53 (Ser-15) were all readily detected in HGPS and RD cells, confirming the activation and signaling of checkpoint pathways in these cells.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data
    § Discussion

    DNA damage accumulation and misshapen nuclei are probably two unrelated phenotypes caused by prelamin A accumulation in HGPS and RD.

    “This suggests that DNA damage accumulation and misshapen nuclei are probably two unrelated phenotypes caused by prelamin A accumulation in HGPS and RD.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning
    § Discussion

    A form of prelamin A (progerin) activated DNA damage responses, leading to replicative senescence.

    “This confirms that a form of prelamin A (progerin) activated DNA damage responses, leading to replicative senescence.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation
    § Discussion

    Independent pathological pathways exist and cooperate with each other in the generation of progeroid phenotypes.

    “suggesting that independent pathological pathways exist and cooperate with each other in the generation of progeroid phenotypes.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Discussion

    Aberrant nuclear morphology is the most obvious phenotype caused by prelamin A accumulation in HGPS and RD fibroblasts.

    “Aberrant nuclear morphology is the most obvious phenotype caused by prelamin A accumulation in HGPS and RD fibroblasts (Goldman et al., 2004; Toth et al., 2005).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Goldman et al., 2004

      Not checked in the free run.

    • cites Toth et al., 2005

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Introduction

    Zmpste24 mutation leads to restrictive dermopathy (RD).

    “Zmpste 24 mutation leads to another progeroid disorder, restrictive dermopathy (RD), which is neonatally lethal (Navarro et al., 2005).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Navarro et al., 2005

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation
    § Introduction

    HGPS and RD have been suggested to be manifestations of the same cellular problem to different degrees.

    “These two diseases have been suggested to be manifestations of the same cellular problem to different degrees (Misteli and Scaffidi, 2005).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Misteli and Scaffidi, 2005

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Discussion

    In unstressed cells, ATR is mainly localized in cytosol, but translocates into the nucleus upon DNA damaging stress such as UV irradiation.

    “In unstressed cells, ATR is mainly localized in cytosol, but translocates into the nucleus upon DNA damaging stress such as UV irradiation.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Abraham, 2001

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Discussion

    p53 knockout can restore proliferative capacity of Zmpste24−/− mouse cells, but only partially reverse other disease phenotypes.

    “Consistent with this notion, p53 knockout can restore proliferative capacity of Zmpste24−/− mouse cells, but only partially reverse other disease phenotypes (Varela et al., 2005), suggesting that independent pathological pathways exist and cooperate with each other in the generation of progeroid phenotypes.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Varela et al., 2005

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation
    § Discussion

    Only partial restoration of S-phase progression is likely due to incomplete repression of DNA damage responses, as even residual kinase activity could be sufficient to enforce a DNA damage checkpoint.

    “That only partial restoration of S-phase progression is observed is likely due to the incomplete repression of the DNA damage responses as even a residual kinase activity could be sufficient to enforce a DNA damage checkpoint (Cortez et al., 2001).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Cortez et al., 2001

      Not checked in the free run.

13 of 13
  • The paper relies on this without support.

    The mechanism by which accumulation of farnesylated prelamin A leads to accelerated aging phenotypes is not understood.

    “The mechanism by which accumulation of farnesylated prelamin A leads to these accelerated aging phenotypes is not understood.”
  • The paper relies on this without support.

    There is no evidence for mutations in DNA repair genes in HGPS and RD cells.

    “As there is no evidence for any mutations in DNA repair genes in HGPS and RD cells, we, and others, hypothesize that prelamin A accumulation affects DNA repair in these syndromes.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Prenylation-incompetent construct has two names

    Minor

    The same prenylation-incompetent LAΔ50 construct is called SIIM in the Results but SSIM in the Methods, leaving its designation inconsistent.

  • Comet assay is called neutral despite alkaline DNA unwinding

    Minor

    The method is described as a neutral comet assay, but its stated procedure exposes the DNA to pH > 13 for 30 minutes before electrophoresis.

2 of 2

The citation lists haven’t been fetched yet

References 36 · Cited by 228

Authors
Liu, Y., Rusinol, A., Sinensky, M., Wang, Y., & Zou, Y.
Affiliations
  • East Tennessee State University (US)
  • Department of Biochemistry and Molecular Biology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA
Venue
Journal of Cell Science
Published
2006-11-15
Volume
119
Issue
22
Pages
4644-4649
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2143571321
Cited by
228
References
36
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 5 · 2018: 14 · 2017: 12 · 2016: 12 · 2015: 18 · 2014: 11 · 2013: 14 · 2012: 13
FWCI
5.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Cell Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
  • San Jose State University Scholar Works (San Jose State University) (submittedVersion)
Funders
National Cancer Institute (R56CA086927, R01CA086927, CA-86927)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
Hutchinson-Gilford progeria syndrome, restrictive dermopathy, progeroid syndromes, prelamin A, farnesyltransferase inhibitors, DNA damage response, ATM, ATR, DNA double-strand breaks, accelerated aging, nuclear morphology, fibroblasts, replication arrest
MeSH terms
Cell Nucleus, DNA Replication, DNA-Binding Proteins, Enzyme Inhibitors, Fibroblasts, Humans, Nuclear Proteins, Progeria, Protein Precursors, Skin Abnormalities, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Lamin Type A, Farnesyltranstransferase, DNA Breaks, Double-Stranded, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review